JP2023533617A - 水分補給を促進するための製剤およびその使用方法 - Google Patents

水分補給を促進するための製剤およびその使用方法 Download PDF

Info

Publication number
JP2023533617A
JP2023533617A JP2023524492A JP2023524492A JP2023533617A JP 2023533617 A JP2023533617 A JP 2023533617A JP 2023524492 A JP2023524492 A JP 2023524492A JP 2023524492 A JP2023524492 A JP 2023524492A JP 2023533617 A JP2023533617 A JP 2023533617A
Authority
JP
Japan
Prior art keywords
aspartic acid
molar ratio
serine
isoleucine
valine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023524492A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023533617A5 (https=
JPWO2022006397A5 (https=
Inventor
ヴィディヤサガル，サダシヴァン
グロッシェ，アストリッド
シュー，シャオドン
リン，シャンシャン
チューヴロント，サムエル
ケンフィック，ロバート
ガット，ステファン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amilyfe LLC
Original Assignee
Amilyfe LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amilyfe LLC filed Critical Amilyfe LLC
Publication of JP2023533617A publication Critical patent/JP2023533617A/ja
Publication of JP2023533617A5 publication Critical patent/JP2023533617A5/ja
Publication of JPWO2022006397A5 publication Critical patent/JPWO2022006397A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
JP2023524492A 2020-07-02 2021-07-01 水分補給を促進するための製剤およびその使用方法 Pending JP2023533617A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063047300P 2020-07-02 2020-07-02
US63/047,300 2020-07-02
PCT/US2021/040090 WO2022006397A1 (en) 2020-07-02 2021-07-01 Formulations for promoting hydration and methods of use thereof

Publications (3)

Publication Number Publication Date
JP2023533617A true JP2023533617A (ja) 2023-08-03
JP2023533617A5 JP2023533617A5 (https=) 2024-07-08
JPWO2022006397A5 JPWO2022006397A5 (https=) 2024-07-08

Family

ID=79314908

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023524492A Pending JP2023533617A (ja) 2020-07-02 2021-07-01 水分補給を促進するための製剤およびその使用方法

Country Status (11)

Country Link
US (2) US12357600B2 (https=)
EP (1) EP4175662A4 (https=)
JP (1) JP2023533617A (https=)
KR (1) KR20230047371A (https=)
CN (1) CN116194136A (https=)
AU (1) AU2021300188A1 (https=)
BR (1) BR112022027124A2 (https=)
CA (1) CA3184691A1 (https=)
IL (1) IL299488A (https=)
MX (1) MX2023000004A (https=)
WO (1) WO2022006397A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11878073B1 (en) * 2022-09-20 2024-01-23 Entrinsic, LLC Generation of hydration-targeted formulations and methods of use therein

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002275059A (ja) * 2001-03-15 2002-09-25 Inst Of Physical & Chemical Res 腎機能障害改善用アミノ酸組成物
WO2010041647A1 (ja) * 2008-10-06 2010-04-15 明治乳業株式会社 アミノ酸組成物を有効成分として含む持久力向上剤、疲労防止剤、又は疲労回復剤
JP2017535591A (ja) * 2014-11-24 2017-11-30 エントリンシック ヘルス ソリューションズ インコーポレイテッド 疾患症状治療用アミノ酸組成物
WO2019007053A1 (zh) * 2017-07-05 2019-01-10 中兴通讯股份有限公司 移动终端及其控制方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3916903A1 (de) * 1989-05-24 1991-02-28 Leopold Pharma Gmbh Waessrige zusammensetzung fuer die parenterale ernaehrung
WO2010017403A2 (en) * 2008-08-06 2010-02-11 Immunopath Profile, Inc. Therapeutic compositions, devices and methods for observing treated tissues
KR101758424B1 (ko) * 2010-09-24 2017-07-14 유니버시티 오브 플로리다 리서치 파운데이션, 인크. 위장 기능을 증진시키기 위한 물질 및 방법
HK1204290A1 (en) * 2012-02-08 2015-11-13 University Of Florida Research Foundation, Inc. Materials and methods for treating diarrhea
EP3522882A4 (en) * 2016-10-04 2020-06-24 The University of Florida Research Foundation Incorporated AMINO ACID COMPOSITIONS AND USES THEREOF
WO2019070753A1 (en) * 2017-10-02 2019-04-11 University Of Florida Research Foundation, Incorporated AMINO ACID COMPOSITIONS AND METHODS FOR TREATING DIARRHEA

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002275059A (ja) * 2001-03-15 2002-09-25 Inst Of Physical & Chemical Res 腎機能障害改善用アミノ酸組成物
WO2010041647A1 (ja) * 2008-10-06 2010-04-15 明治乳業株式会社 アミノ酸組成物を有効成分として含む持久力向上剤、疲労防止剤、又は疲労回復剤
JP2017535591A (ja) * 2014-11-24 2017-11-30 エントリンシック ヘルス ソリューションズ インコーポレイテッド 疾患症状治療用アミノ酸組成物
WO2019007053A1 (zh) * 2017-07-05 2019-01-10 中兴通讯股份有限公司 移动终端及其控制方法

Also Published As

Publication number Publication date
US12357600B2 (en) 2025-07-15
US20230149335A1 (en) 2023-05-18
US20250367154A1 (en) 2025-12-04
MX2023000004A (es) 2023-03-06
CA3184691A1 (en) 2022-12-30
WO2022006397A1 (en) 2022-01-06
KR20230047371A (ko) 2023-04-07
AU2021300188A1 (en) 2023-02-02
EP4175662A1 (en) 2023-05-10
CN116194136A (zh) 2023-05-30
BR112022027124A2 (pt) 2023-03-07
EP4175662A4 (en) 2024-07-17
IL299488A (en) 2023-02-01

Similar Documents

Publication Publication Date Title
Michaelsson Zinc therapy in acrodermatitis enteropathica
Nabuurs et al. Effects of weaning and enterotoxigenic Escherichia coli on net absorption in the small intestine of pigs
CN107106527B (zh) 用于治疗疾病症状的氨基酸组合物
EA033940B1 (ru) Пероральный регидратационный раствор и способ его приготовления
US20250367154A1 (en) Formulations for promoting hydration and methods of use thereof
Nagy et al. Colostrum protein concentrate enhances intestinal adaptation after massive small bowel resection in juvenile pigs
Scott et al. Calf diarrhoea
WO2013139274A1 (zh) 用于治疗循环血容量不足或失水伴失盐的丙酮酸钠（Pyruvate）口服补液盐组合物
Lewis et al. Treatment of the calf with diarrhea
JP2019034953A (ja) 体重増加用化合物の長期使用のための組成物と方法
Toribio et al. Diseases of the foal
Whitehead et al. Neonatology and neonatal disorders
Deane et al. Examination, Therapeutics, and Monitoring of the Urinary System
CN115916185A (zh) 用于治疗腹泻的制剂和方法
Sharma et al. An intriguing case of acute encephalopathy: lesson learned from a constipated man
CN120130576B (zh) 左旋肉碱作为猫科动物aim蛋白激活剂的用途以及用于猫科动物改善肾功能的用途
Arruda et al. Distal renal tubular acidosis: molecular and clinical aspects
JPH0710770A (ja) アミノ酸輸液
Lennard-Jones et al. Historical overview of intestinal failure
Pikul et al. Intensive care in the clinics of childhood infectious diseases
Shah Non-oliguric renal failure—a presentation of leptospirosis
MISHINA et al. Medical dissolution of struvite nephrolithiasis using amino acid preparation in dogs
Smith Treating scouring beef and dairy calves
CN119924421A (zh) L-半胱氨酸作为猫科动物aim蛋白激活剂的用途以及用于猫科动物改善肾功能的用途
CN120188851A (zh) 维生素b1作为猫科动物aim蛋白激活剂的用途以及用于猫科动物改善肾功能的用途

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240628

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240628

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250805

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20251030

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260205

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20260205